BMJ 1998;316:1022 ( 28 March )

Letters

Decline in cognitive function in Parkinson's disease may be due to dementia with Lewy bodies

The first 150 words of the full text of this article appear below.

EDITOR---Donnellan et al report on four patients with Parkinson's disease in whom prescription of oxybutynin was associated with worsening cognitive function.1 Cognitive impairment in Parkinson's disease is common. It has been suggested that when a progressive decline in cognitive function in Parkinson's disease is accompanied by visual hallucinations and fluctuating cognition a secondary diagnosis of dementia with Lewy bodies is made.2 Dementia with Lewy bodies may present with neuropsychiatric features in the absence of parkinsonism and, indeed, is probably the second most common form of dementia in old age, only Alzheimer's disease being more common.

Previous case series of patients with dementia with Lewy bodies have shown exacerbations of confusion with orphenadrine (one case), little or no effect on confusion with benzhexol, and no effect on fluctuating confusion of withdrawing anticholinergic drugs in a 70 year old woman with visual hallucinations.3 A prospective study of dementia with Lewy bodies . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Informed consent: edging forwards (and backwards)
Richard Smith
BMJ 1998 316: 949-951. [Extract] [Full Text] [PDF]

Lesson of the week: Oxybutynin and cognitive dysfunction
C A Donnellan, L Fook, P McDonald, and J R Playfer
BMJ 1997 315: 1363-1364. [Extract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ